Brain gray matter alterations in first episodes of depression: A meta-analysis of whole-brain studies

Neuroscience and Biobehavioral Reviews

Volumn 60, Issue , 2016, Pages 43-50

  Zhang, Huawei ^a   Li, Lei ^a   Wu, Min ^a   Chen, Ziqi ^a   Hu, Xinyu ^a   Chen, Ying ^a   Zhu, Hongyan ^a   Jia, Zhiyun ^a   Gong, Qiyong ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Effect size signed differential mapping (ES SDM); First episode depression; Meta analysis; Voxel based morphometry (VBM)

Indexed keywords

AMYGDALOID NUCLEUS; BRAIN FUNCTION; BRAIN MAPPING; BRAIN SIZE; DEPRESSION; EFFECT SIZE SIGNED DIFFERENTIAL MAPPING; EMOTIONALITY; FIRST EPISODE DEPRESSION; GRAY MATTER; HUMAN; INSULA; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; SUPERIOR FRONTAL GYRUS; SUPPLEMENTARY MOTOR AREA; SYSTEMATIC REVIEW; VOXEL BASED MORPHOMETRY; ACUTE DISEASE; ANIMAL; BRAIN; META ANALYSIS; PATHOLOGY;

KERATAN SULFATE; LUM PROTEIN, HUMAN; LUMICAN; PROTEOCHONDROITIN SULFATE;

ACUTE DISEASE; ANIMALS; BRAIN; CHONDROITIN SULFATE PROTEOGLYCANS; DEPRESSIVE DISORDER; GRAY MATTER; HUMANS; KERATAN SULFATE; LUMICAN;

EID: 84949752473     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.10.011     Document Type: Review

References (64)

1. Aston C., Jiang L., Sokolov B.P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol. Psychiatry 2005, 10:309-322.
2. Bora E., Fornito A., Pantelis C., Yucel M. Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. J. Affect. Disord. 2012, 138:9-18.
3. Bracht T., Federspiel A., Schnell S., Horn H., Hofle O., Wiest R., Dierks T., Strik W., Muller T.J., Walther S. Cortico-cortical white matter motor pathway microstructure is related to psychomotor retardation in major depressive disorder. PLoS ONE 2012, 7:e52238.
4. Canbeyli R. Sensorimotor modulation of mood and depression: an integrative review. Behav. Brain. Res. 2010, 207:249-264.
5. Cheng Y.Q., Xu J., Chai P., Li H.J., Luo C.R., Yang T., Li L., Shan B.C., Xu X.F., Xu L. Brain volume alteration and the correlations with the clinical characteristics in drug-naive first-episode MDD patients: a voxel-based morphometry study. Neurosci. Lett. 2010, 480:30-34.
6. Costafreda S.G., Brammer M.J., David A.S., Fu C.H. Predictors of amygdala activation during the processing of emotional stimuli: a meta-analysis of 385 PET and fMRI studies. Brain Res. Rev. 2008, 58:57-70.
7. Cusi A.M., Nazarov A., Holshausen K., Macqueen G.M., McKinnon M.C. Systematic review of the neural basis of social cognition in patients with mood disorders. J. Psychiatry Neurosci. 2012, 37:154-169.
8. Damasio A. Mental self: the person within. Nature 2003, 423:227.
9. Du M., Liu J., Chen Z., Huang X., Li J., Kuang W., Yang Y., Zhang W., Zhou D., Bi F., Kendrick K.M., Gong Q. Brain grey matter volume alterations in late-life depression. J. Psychiatry Neurosci. 2014, 39:397-406.
10. Du M.Y., Wu Q.Z., Yue Q., Li J., Liao Y., Kuang W.H., Huang X.Q., Chan R.C., Mechelli A., Gong Q.Y. Voxelwise meta-analysis of gray matter reduction in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 36:11-16.
11. Exner C., Koschack J., Irle E. The differential role of premotor frontal cortex and basal ganglia in motor sequence learning: evidence from focal basal ganglia lesions. Learn. Mem. 2002, 9:376-386.
12. Exner C., Lange C., Irle E. Impaired implicit learning and reduced pre-supplementary motor cortex size in early-onset major depression with melancholic features. J. Affect. Disord. 2009, 119:156-162.
13. Fitzgerald P.B., Laird A.R., Maller J., Daskalakis Z.J. A meta-analytic study of changes in brain activation in depression. Hum. Brain Mapp. 2008, 29:683-695.
14. Frodl T., Meisenzahl E.M., Zetzsche T., Born C., Jager M., Groll C., Bottlender R., Leinsinger G., Moller H.J. Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol. Psychiatry 2003, 53:338-344.
15. Fusar-Poli P., Radua J., McGuire P., Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophr. Bull. 2012, 38:1297-1307.
16. Glover M.E., Pugh P.C., Jackson N.L., Cohen J.L., Fant A.D., Akil H., Clinton S.M. Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats. Neuroscience 2015, 284:775-797.
17. Graff-Guerrero A., Gonzalez-Olvera J., Mendoza-Espinosa Y., Vaugier V., Garcia-Reyna J.C. Correlation between cerebral blood flow and items of the Hamilton Rating Scale for depression in antidepressant-naive patients. J. Affect. Disord. 2004, 80:55-63.
18. Hickie I.B., Naismith S.L., Ward P.B., Scott E.M., Mitchell P.B., Schofield P.R., Scimone A., Wilhelm K., Parker G. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J. Affect. Disord. 2007, 98:137-142.
19. Jahn A.L., Fox A.S., Abercrombie H.C., Shelton S.E., Oakes T.R., Davidson R.J., Kalin N.H. Subgenual prefrontal cortex activity predicts individual differences in hypothalamic-pituitary-adrenal activity across different contexts. Biol. Psychiatry 2010, 67:175-181.
20. Jansson L., Wennstrom M., Johanson A., Tingstrom A. Glial cell activation in response to electroconvulsive seizures. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1119-1128.
21. Jiang L., Liu C., Tong J., Mao R., Chen D., Wang H., Huang J., Li L. Fluoxetine pretreatment promotes neuronal survival and maturation after auditory fear conditioning in the rat amygdala. PLoS ONE 2014, 9:e89147.
22. Jorgensen A., Magnusson P., Hanson L.G., Kirkegaard T., Benveniste H., Lee H., Svarer C., Mikkelsen J.D., Fink-Jensen A., Knudsen G.M., Paulson O.B., Bolwig T.G., Jorgensen M.B. Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression. Acta Psychiatr. Scand. 2015, (in press). 10.1111/acps.12462.
23. Kong L., Wu F., Tang Y., Ren L., Kong D., Liu Y., Xu K., Wang F. Frontal-subcortical volumetric deficits in single episode, medication-naive depressed patients and the effects of 8 weeks fluoxetine treatment: a VBM-DARTEL study. PLoS ONE 2014, 9:e79055.
24. Koolschijn P.C., van Haren N.E., Lensvelt-Mulders G.J., Hulshoff Pol H.E., Kahn R.S. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum. Brain Mapp. 2009, 30:3719-3735.
25. Kronenberg G., Tebartz van Elst L., Regen F., Deuschle M., Heuser I., Colla M. Reduced amygdala volume in newly admitted psychiatric in-patients with unipolar major depression. J. Psychiatr. Res. 2009, 43:1112-1117.
26. Lai C.H., Hsu Y.Y., Wu Y.T. First episode drug-naive major depressive disorder with panic disorder: gray matter deficits in limbic and default network structures. Eur. Neuropsychopharmacol. 2010, 20:676-682.
27. Lai C.H., Wu Y.T. Changes in gray matter volume of remitted first-episode, drug-naive, panic disorder patients after 6-week antidepressant therapy. J. Psychiatr. Res. 2013, 47:122-127.
28. Lai C.H., Wu Y.T. Frontal-insula gray matter deficits in first-episode medication-naive patients with major depressive disorder. J. Affect. Disord. 2014, 160:74-79.
29. Li H., Wei D., Sun J., Chen Q., Zhang Q., Qiu J. Brain structural alterations associated with young women with subthreshold depression. Sci. Rep. 2015, 5:9707.
30. Li L., Wu M., Liao Y., Ouyang L., Du M., Lei D., Chen L., Yao L., Huang X., Gong Q. Grey matter reduction associated with posttraumatic stress disorder and traumatic stress. Neurosci. Biobehav. Rev. 2014, 43:163-172.
31. Liu F., Hu M., Wang S., Guo W., Zhao J., Li J., Xun G., Long Z., Zhang J., Wang Y., Zeng L., Gao Q., Wooderson S.C., Chen J., Chen H. Abnormal regional spontaneous neural activity in first-episode, treatment-naive patients with late-life depression: a resting-state fMRI study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39:326-331.
32. Lorenzetti V., Allen N.B., Fornito A., Yucel M. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J. Affect. Disord. 2009, 117:1-17.
33. Lorenzetti V., Allen N.B., Whittle S., Yucel M. Amygdala volumes in a sample of current depressed and remitted depressed patients and healthy controls. J. Affect. Disord. 2010, 120:112-119.
34. Ma C., Ding J., Li J., Guo W., Long Z., Liu F., Gao Q., Zeng L., Zhao J., Chen H. Resting-state functional connectivity bias of middle temporal gyrus and caudate with altered gray matter volume in major depression. PLoS ONE 2012, 7:e45263.
35. Ma Y. Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis. Mol. Psychiatry 2015, 20:311-319.
36. Malykhin N.V., Carter R., Hegadoren K.M., Seres P., Coupland N.J. Fronto-limbic volumetric changes in major depressive disorder. J. Affect. Disord. 2012, 136:1104-1113.
37. Mervaala E., Fohr J., Kononen M., Valkonen-Korhonen M., Vainio P., Partanen K., Partanen J., Tiihonen J., Viinamaki H., Karjalainen A.K., Lehtonen J. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol. Med. 2000, 30:117-125.
38. Nitsche M.A., Schauenburg A., Lang N., Liebetanz D., Exner C., Paulus W., Tergau F. Facilitation of implicit motor learning by weak transcranial direct current stimulation of the primary motor cortex in the human. J. Cogn. Neurosci. 2003, 15:619-626.
39. Pavuluri M.N., Passarotti A.M., Fitzgerald J.M., Wegbreit E., Sweeney J.A. Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study. Am. Acad. Child Adolesc. Psychiatry 2012, 51:157-170. (e155).
40. Peng D.H., Jiang K.D., Fang Y.R., Xu Y.F., Shen T., Long X.Y., Liu J., Zang Y.F. Decreased regional homogeneity in major depression as revealed by resting-state functional magnetic resonance imaging. Chin. Med. J. (Engl.) 2011, 124:369-373.
41. Peng J., Liu J., Nie B., Li Y., Shan B., Wang G., Li K. Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: a voxel-based morphometry study. Eur. J. Radiol. 2011, 80:395-399.
42. Perico C.A., Skaf C.R., Yamada A., Duran F., Buchpiguel C.A., Castro C.C., Soares J.C., Busatto G.F. Relationship between regional cerebral blood flow and separate symptom clusters of major depression: a single photon emission computed tomography study using statistical parametric mapping. Neurosci. Lett. 2005, 384:265-270.
43. Phillips M.L., Chase H.W., Sheline Y.I., Etkin A., Almeida J.R., Deckersbach T., Trivedi M.H. Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches. Am. J. Psychiatry 2015, 172:124-138.
44. Poeppl T.B., Frank E., Schecklmann M., Kreuzer P.M., Prasser S.J., Rupprecht R., Hajak G., Langguth B., Landgrebe M. Amygdalohippocampal neuroplastic changes following neuroleptic treatment with quetiapine in first-episode schizophrenia. Int. J. Neuropsychopharmacol. 2014, 17:833-843.
45. Radua J., Mataix-Cols D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br. J. Psychiatry 2009, 195:393-402.
46. Reiman E.M., Lane R.D., Ahern G.L., Schwartz G.E., Davidson R.J., Friston K.J., Yun L.S., Chen K. Neuroanatomical correlates of externally and internally generated human emotion. Am. J. Psychiatry 1997, 154:918-925.
47. Salimi-Khorshidi G., Smith S.M., Keltner J.R., Wager T.D., Nichols T.E. Meta-analysis of neuroimaging data: a comparison of image-based and coordinate-based pooling of studies. NeuroImage 2009, 45:810-823.
48. Serra-Blasco M., Portella M.J., Gomez-Anson B., de Diego-Adelino J., Vives-Gilabert Y., Puigdemont D., Granell E., Santos A., Alvarez E., Perez V. Effects of illness duration and treatment resistance on grey matter abnormalities in major depression. Br. J. Psychiatry 2013, 202:434-440.
49. Shang J., Fu Y., Ren Z., Zhang T., Du M., Gong Q., Lui S., Zhang W. The common traits of the ACC and PFC in anxiety disorders in the DSM-5: meta-analysis of voxel-based morphometry studies. PLoS ONE 2014, 9:e93432.
50. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss. Am. J. Psychiatry 2003, 160:1516-1518.
51. Shen T., Qiu M., Li C., Zhang J., Wu Z., Wang B., Jiang K., Peng D. Altered spontaneous neural activity in first-episode, unmedicated patients with major depressive disorder. NeuroReport 2014, 25:1302-1307.
52. Sliz D., Hayley S. Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research. Front. Hum. Neurosci. 2012, 6:323.
53. Smith R., Chen K., Baxter L., Fort C., Lane R.D. Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex. J. Affect. Disord. 2013, 146:414-419.
54. Stratmann M., Konrad C., Kugel H., Krug A., Schoning S., Ohrmann P., Uhlmann C., Postert C., Suslow T., Heindel W., Arolt V., Kircher T., Dannlowski U. Insular and hippocampal gray matter volume reductions in patients with major depressive disorder. PLoS ONE 2014, 9:e102692.
55. Su L., Cai Y., Xu Y., Dutt A., Shi S., Bramon E. Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies. BMC Psychiatry 2014, 14:321.
56. Tang Y., Wang F., Xie G., Liu J., Li L., Su L., Liu Y., Hu X., He Z., Blumberg H.P. Reduced ventral anterior cingulate and amygdala volumes in medication-naive females with major depressive disorder: a voxel-based morphometric magnetic resonance imaging study. Psychiatry Res. 2007, 156:83-86.
57. Tendolkar I., van Beek M., van Oostrom I., Mulder M., Janzing J., Voshaar R.O., van Eijndhoven P. Electroconvulsive therapy increases hippocampal and amygdala volume in therapy refractory depression: a longitudinal pilot study. Psychiatry Res. 2013, 214:197-203.
58. Wager T.D., Smith E.E. Neuroimaging studies of working memory: a meta-analysis. Cogn. Affect. Behav. Neurosci. 2003, 3:255-274.
59. Wang L., Dai W., Su Y., Wang G., Tan Y., Jin Z., Zeng Y., Yu X., Chen W., Wang X., Si T. Amplitude of low-frequency oscillations in first-episode, treatment-naive patients with major depressive disorder: a resting-state functional MRI study. PLoS ONE 2012, 7:e48658.
60. Wennstrom M., Hellsten J., Tingstrom A. Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala. Biol. Psychiatry 2004, 55:464-471.
61. Whittle S., Lichter R., Dennison M., Vijayakumar N., Schwartz O., Byrne M.L., Simmons J.G., Yucel M., Pantelis C., McGorry P., Allen N.B. Structural brain development and depression onset during adolescence: a prospective longitudinal study. Am. J. Psychiatry 2014, 171:564-571.
62. Zhang X., Yao S., Zhu X., Wang X., Zhong M. Gray matter volume abnormalities in individuals with cognitive vulnerability to depression: a voxel-based morphometry study. J. Affect. Disord. 2012, 136:443-452.
63. Zhao Y.J., Du M.Y., Huang X.Q., Lui S., Chen Z.Q., Liu J., Luo Y., Wang X.L., Kemp G.J., Gong Q.Y. Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis. Psychol. Med. 2014, 44:2927-2937.
64. Zou K., Deng W., Li T., Zhang B., Jiang L., Huang C., Sun X. Changes of brain morphometry in first-episode, drug-naive, non-late-life adult patients with major depression: an optimized voxel-based morphometry study. Biol. Psychiatry 2010, 67:186-188.